Clinical Center; Notice of Closed Meeting, 13087-13088 [2024-03441]

Download as PDF Federal Register / Vol. 89, No. 35 / Wednesday, February 21, 2024 / Notices approved collection; Title of Information Collection: Administrative Requirements for Section 6071 of the Deficit Reduction Act; Use: State Operational Protocols should provide enough information such that: the CMS Project Officer and other federal officials may use it to understand the operation of the demonstration, prepare for potential site visits without needing additional information, or both; the State Project Director can use it as the manual for program implementation; and external stakeholders may use it to understand the operation of the demonstration. The financial information collection is used in our financial statements and shared with the auditors who validate CMS’ financial position. The Money Follows the Person Rebalancing Demonstration (MFP) Finders File, MFP Program Participation Data file, and MFP Services File are used by the national evaluation contractor to assess program outcomes while we use the information to monitor program implementation. The MFP Quality of Life data is used by the national evaluation contractor to assess program outcomes. The evaluation is used to determine how participants’ quality of life changes after transitioning to the community. The semi-annual progress report is used by the national evaluation contractor and CMS to monitor program implementation at the grantee level. Form Number: CMS– 10249 (OMB control number: 0938– 1053); Frequency: Yearly, quarterly, and semi-annually; Affected Public: State, Local, or Tribal Governments; Number of Respondents: 41; Total Annual Responses: 410; Total Annual Hours: 4,326. (For policy questions regarding this collection contact Alicia Ryce at 410–786–1075.) William N. Parham, III, Director, Division of Information Collections and Regulatory Impacts, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2024–03476 Filed 2–20–24; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES khammond on DSKJM1Z7X2PROD with NOTICES Administration for Community Living Administration on Disabilities, The President’s Committee for People With Intellectual Disabilities Administration for Community Living, HHS. ACTION: Notice. AGENCY: The President’s Committee for People with Intellectual Disabilities SUMMARY: VerDate Sep<11>2014 17:43 Feb 20, 2024 Jkt 262001 (PCPID) will host a virtual meeting for its members to address issues surrounding Home and Community Based Services (HCBS) to be examined in the Committee’s Report to the President. All the PCPID meetings, in any format, are open to the public. This virtual meeting will be conducted in a discussion format with committee members addressing the issues and recommendations identified by PCPID workgroups proposing to be incorporated in the PCPID Report to the President. DATES: The meeting will take place virtually on March 21, 2024 from 12:00 p.m. to 5:00 p.m. (EST). Comments received by March 12, 2024 will be shared with the PCPID at the March 21, 2024 meeting. ADDRESSES: Comments: Comments and suggestions may be shared through the following ACL.gov link: https://acl.gov/ form/pcpid. Webinar/Conference Call: The virtual meeting is scheduled for Thursday, March 21, 2024 from 12:00 p.m. to 5:00 p.m. (EST) and may end early if discussions are finished. The meeting is open to the public and will be held through a zoom meeting platform. In order to observe the proceedings, you must register in advance of the meeting at the following link: https:// www.zoomgov.com/webinar/register/ WN_HnpxBCCsSUGJv6SX_O_YlQ. FOR FURTHER INFORMATION CONTACT: Mr. David Jones, Director, Office of Intellectual Developmental Disabilities, 330 C Street SW, Switzer Building, Room 1126, Washington, DC 20201. Telephone: 202–795–7367. Fax: 202– 795–7334. Email: David.Jones@ acl.hhs.gov. SUPPLEMENTARY INFORMATION: Agenda: The Committee will collectively discuss the HCBS issues and recommendations identified by four PCPID workgroups as it relates to the areas of direct support professionals, employment, community living, and Federal support programs. This discussion will help develop a framework for the preparation of the PCPID Report to the President. Comments: Stakeholder input is very important to the PCPID. Comments and suggestions especially from people with intellectual disabilities, are welcomed. If there are comments related to HCBS or other areas that you would like to inform the PCPID, please share them through the following ACL.gov link: https://acl.gov/form/pcpid. Background Information on the Committee: The PCPID acts in an advisory capacity to the President and PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 13087 the Secretary of Health and Human Services on a broad range of topics relating to programs, services and support for individuals with intellectual disabilities. The function of PCPID is to: (1) provide such advice concerning intellectual disabilities as the President or the Secretary of Health and Human Services may request; and (2) provide advice to the President and the Secretary of Health and Human Services to promote full participation of people with intellectual disabilities in their communities, such as: (A) expanding educational opportunities; (B) promoting housing opportunities; (C) expanding opportunities for competitive integrated employment; (D) improving accessible transportation options; (E) protecting rights and preventing abuse; and (F) increasing access to assistive and universally designed technologies; and (3) provide advice to the President and the Secretary of Health and Human Services to help advance racial equity and support for people with intellectual disabilities within underserved communities. Statutory Authority: E.O. 14048, 85 FR 57313. Dated: February 14, 2024. Jill Jacobs, Commissioner, Administration on Disabilities. [FR Doc. 2024–03458 Filed 2–20–24; 8:45 am] BILLING CODE 4154–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Clinical Center; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Board of Scientific Counselors of the NIH Clinical Center. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended, for the review, discussion, and evaluation of individual intramural programs and projects conducted by the Clinical Center, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors of the NIH Clinical Center. Date: March 25, 2024. Time: 11:00 a.m. to 5:00 p.m. E:\FR\FM\21FEN1.SGM 21FEN1 13088 Federal Register / Vol. 89, No. 35 / Wednesday, February 21, 2024 / Notices Agenda: To review and evaluate the Pediatrics and Critical Care Medicine Department, Emerging Pathogens Section. Place: Clinical Center, 10 Center Drive, Bethesda, MD 20892 (Virtual). Name of Committee: Board of Scientific Counselors of the NIH Clinical Center. Date: March 26, 2024. Time: 11:00 a.m. to 12:30 p.m. Agenda: To review and evaluate the Pediatrics and Critical Care Medicine Department, Emerging Pathogens Section. Place: Clinical Center, 10 Center Drive, Bethesda, MD 20892 (Virtual). Contact Person: Ronald Neumann, M.D., Deputy Scientific Director, Clinical Center, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, 301–496–6455, rneumann@cc.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Patricia B. Hansberger, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2024–03441 Filed 2–20–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome Research Institute; Notice of Closed Meeting khammond on DSKJM1Z7X2PROD with NOTICES Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Human Genome Research Institute Special Emphasis Panel; Center for Inherited Disease Research (CIDR). Date: March 7, 2024. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892. VerDate Sep<11>2014 17:43 Feb 20, 2024 Jkt 262001 Contact Person: Rudy O. Pozzatti, Ph.D., Scientific Review Officer, Scientific Review Branch, National Human Genome Research Institute, 6700B Rockledge Drive, MSC 6908, Rockville, MD 20892, (301) 402–8739, pozzattr@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) Dated: February 15, 2024. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–03520 Filed 2–20–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel; Preteen Suicide Prevention. Date: March 19, 2024. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. Contact Person: Evon Abisaid, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, Rockville, MD 20852, (301) 827–0399, ereifejes@mail.nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel; Precision HIV Health: Integrating Data and Implementation Science. Date: March 20, 2024. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. Contact Person: Jasenka Borzan, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 Mental Health, Neuroscience Center, 6001 Executive Blvd., Bethesda, MD 20892, 301– 435–1260, jasenka.borzan@nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel; Pathway to Independence Awards (K99/R00). Date: March 22, 2024. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. Contact Person: David W. Miller, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, Neuroscience Center, 6001 Executive Blvd., Bethesda, MD 20892–9608, 301–443–9734, millerda@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.242, Mental Health Research Grants, National Institutes of Health, HHS) Dated: February 15, 2024. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–03522 Filed 2–20–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; Review of NIH Pathway to Independence Award (K99/R00) Applications. Date: March 11–12, 2024. Time: 9:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute of General Medical Sciences, Natcher Building, 45 Center Drive, Bethesda, Maryland 20892 (Virtual Meeting). Contact Person: Lee Warren Slice, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical E:\FR\FM\21FEN1.SGM 21FEN1

Agencies

[Federal Register Volume 89, Number 35 (Wednesday, February 21, 2024)]
[Notices]
[Pages 13087-13088]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-03441]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Clinical Center; Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Board of Scientific 
Counselors of the NIH Clinical Center.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), Title 5 
U.S.C., as amended, for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the Clinical 
Center, including consideration of personnel qualifications and 
performance, and the competence of individual investigators, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: Board of Scientific Counselors of the NIH 
Clinical Center.
    Date: March 25, 2024.
    Time: 11:00 a.m. to 5:00 p.m.

[[Page 13088]]

    Agenda: To review and evaluate the Pediatrics and Critical Care 
Medicine Department, Emerging Pathogens Section.
    Place: Clinical Center, 10 Center Drive, Bethesda, MD 20892 
(Virtual).

    Name of Committee: Board of Scientific Counselors of the NIH 
Clinical Center.
    Date: March 26, 2024.
    Time: 11:00 a.m. to 12:30 p.m.
    Agenda: To review and evaluate the Pediatrics and Critical Care 
Medicine Department, Emerging Pathogens Section.
    Place: Clinical Center, 10 Center Drive, Bethesda, MD 20892 
(Virtual).
    Contact Person: Ronald Neumann, M.D., Deputy Scientific 
Director, Clinical Center, National Institutes of Health, 10 Center 
Drive, Bethesda, MD 20892, 301-496-6455, [email protected].

    Any interested person may file written comments with the committee 
by forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person.

Patricia B. Hansberger,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-03441 Filed 2-20-24; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.